Brian MacKenna

12.7k total citations
42 papers, 203 citations indexed

About

Brian MacKenna is a scholar working on General Health Professions, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, Brian MacKenna has authored 42 papers receiving a total of 203 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in General Health Professions, 10 papers in Infectious Diseases and 9 papers in Economics and Econometrics. Recurrent topics in Brian MacKenna's work include COVID-19 Clinical Research Studies (9 papers), COVID-19 and healthcare impacts (8 papers) and Antibiotic Use and Resistance (7 papers). Brian MacKenna is often cited by papers focused on COVID-19 Clinical Research Studies (9 papers), COVID-19 and healthcare impacts (8 papers) and Antibiotic Use and Resistance (7 papers). Brian MacKenna collaborates with scholars based in United Kingdom, United States and Ireland. Brian MacKenna's co-authors include Ben Goldacre, Helen J Curtis, Alex J Walker, Seb Bacon, Richard Croker, Amir Mehrkar, Louis Fisher, Peter Inglesby, Georgia C. Richards and Aziz Sheikh and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ and PLoS Medicine.

In The Last Decade

Brian MacKenna

37 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian MacKenna United Kingdom	9	61	46	35	32	32	42	203
Jung‐ho Shin Japan	11	55 0.9×	44 1.0×	32 0.9×	100 3.1×	51 1.6×	32	266
Matilde Boccia Italy	5	31 0.5×	162 3.5×	19 0.5×	63 2.0×	32 1.0×	5	387
Rowena Griffiths United Kingdom	10	34 0.6×	26 0.6×	23 0.7×	107 3.3×	47 1.5×	31	256
Matthew Gold United States	6	19 0.3×	113 2.5×	27 0.8×	13 0.4×	37 1.2×	23	261
Michael Benigno United States	8	26 0.4×	107 2.3×	45 1.3×	57 1.8×	31 1.0×	20	295
Vanessa Marvin United Kingdom	11	58 1.0×	23 0.5×	67 1.9×	86 2.7×	34 1.1×	19	307
Kelly Compton United States	7	56 0.9×	18 0.4×	42 1.2×	43 1.3×	43 1.3×	11	212
María Fernanda Carrillo-Vega Mexico	8	30 0.5×	116 2.5×	32 0.9×	62 1.9×	11 0.3×	17	274
E. Karampli Greece	11	75 1.2×	11 0.2×	90 2.6×	12 0.4×	31 1.0×	36	271
Scott Husak United States	10	117 1.9×	49 1.1×	84 2.4×	30 0.9×	83 2.6×	16	398

Countries citing papers authored by Brian MacKenna

Since Specialization

Citations

This map shows the geographic impact of Brian MacKenna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian MacKenna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian MacKenna more than expected).

Fields of papers citing papers by Brian MacKenna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian MacKenna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian MacKenna. The network helps show where Brian MacKenna may publish in the future.

Co-authorship network of co-authors of Brian MacKenna

This figure shows the co-authorship network connecting the top 25 collaborators of Brian MacKenna. A scholar is included among the top collaborators of Brian MacKenna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian MacKenna. Brian MacKenna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacKenna, Brian, Richard Croker, Alex J Walker, et al.. (2025). Variation in duration of repeat prescriptions: a primary care cohort study in England. British Journal of General Practice. 75(756). e448–e456.

Mattsson, Molly, Michelle Flood, Brian MacKenna, et al.. (2025). Trends in analgesia prescribing in primary care in Ireland and England between 2014 and 2022: A repeated cross‐sectional study. British Journal of Clinical Pharmacology. 91(12). 3432–3444.

Glover, R. E., Mirza Lalani, Thomas Allen, et al.. (2025). A mixed methods protocol for an impact and implementation evaluation of the Pharmacy First Services for management of common conditions in England. International Journal of Pharmacy Practice. 33(2). 152–161. 1 indexed citations

Bechman, Katie, Amelia Green, Mark Russell, et al.. (2024). The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19. Journal of Infection. 89(3). 106227–106227. 1 indexed citations

Samuel, Miriam, Sophie V. Eastwood, Caroline E Morton, et al.. (2024). Weight trends among adults with diabetes or hypertension during the COVID-19 pandemic: an observational study using OpenSAFELY. British Journal of General Practice. 74(748). e767–e776. 1 indexed citations

Wong, David, Darren M. Ashcroft, Kieran Hand, et al.. (2024). Exploring Prior Antibiotic Exposure Characteristics for COVID-19 Hospital Admission Patients: OpenSAFELY. Antibiotics. 13(6). 566–566. 1 indexed citations

Santhakumaran, Shalini, Louis Fisher, Viyaasan Mahalingasivam, et al.. (2024). Identification of patients undergoing chronic kidney replacement therapy in primary and secondary care data: validation study based on OpenSAFELY and UK Renal Registry. SHILAP Revista de lepidopterología. 3(1). e000807–e000807. 2 indexed citations

Samuel, Miriam, Sophie V. Eastwood, Caroline E Morton, et al.. (2024). Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform. PLoS Medicine. 21(6). e1004398–e1004398. 5 indexed citations

Horne, Elsie, William Hulme, Edward P K Parker, et al.. (2024). Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPP. Epidemiology. 35(4). 568–578. 1 indexed citations

10.

Fisher, Louis, Katie Smith, Carol Roberts, et al.. (2024). Safety of direct-acting oral anticoagulant (DOAC) prescribing: OpenSAFELY-TPP analysis of 20.5 million adults’ electronic health records. BJGP Open. 8(2). BJGPO.2023.0163–BJGPO.2023.0163. 1 indexed citations

11.

Green, Mark, Martin McKee, Jon Massey, et al.. (2024). Trends in inequalities in avoidable hospitalisations across the COVID-19 pandemic: a cohort study of 23.5 million people in England. BMJ Open. 14(1). e077948–e077948.

12.

Pate, Alexander, Darren M. Ashcroft, Ben Goldacre, et al.. (2023). The impact of COVID-19 on antibiotic prescribing in primary care in England: Evaluation and risk prediction of appropriateness of type and repeat prescribing. Journal of Infection. 87(1). 1–11. 7 indexed citations

13.

Parker, Edward P K, Elsie Horne, William Hulme, et al.. (2023). Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study. The Lancet Regional Health - Europe. 30. 100636–100636. 8 indexed citations

14.

Pate, Alexander, Darren M. Ashcroft, Ben Goldacre, et al.. (2023). Impact of COVID-19 on broad-spectrum antibiotic prescribing for common infections in primary care in England: a time-series analyses using OpenSAFELY and effects of predictors including deprivation. The Lancet Regional Health - Europe. 30. 100653–100653. 10 indexed citations

15.

Fonseca, Martina, Brian MacKenna, Amir Mehrkar, et al.. (2023). The Use of Online Consultation Systems or Remote Consulting in England Characterized Through the Primary Care Health Records of 53 Million People in the OpenSAFELY Platform: Retrospective Cohort Study. JMIR Public Health and Surveillance. 10. e46485–e46485. 1 indexed citations

16.

Mattsson, Molly, Fiona Boland, Michelle Flood, et al.. (2023). The impact of lidocaine plaster prescribing reduction strategies: A comparison of two national health services in Europe. British Journal of Clinical Pharmacology. 89(8). 2349–2358. 4 indexed citations

17.

Hulme, William, Elsie Horne, Edward P K Parker, et al.. (2023). Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP. BMJ. 380. e072808–e072808. 17 indexed citations

18.

Richards, Georgia C., Jeffrey K Aronson, Brian MacKenna, et al.. (2022). Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study. Drug Safety. 45(3). 237–247. 13 indexed citations

19.

MacKenna, Brian, Helen J Curtis, Lisa Hopcroft, et al.. (2022). Identifying Patterns of Clinical Interest in Clinicians’ Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review. JMIR Medical Informatics. 10(12). e41200–e41200.

20.

Mattsson, Molly, Fiona Boland, Michelle Flood, et al.. (2022). Evaluation of policies and practices to support safe and appropriate analgesic and sedative prescribing: The CDRx (controlled drug prescribing) protocol. Research in Social and Administrative Pharmacy. 18(9). 3588–3595. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact